---
document_datetime: 2023-09-21 17:13:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aclasta-epar-all-authorised-presentations_en.pdf
document_name: aclasta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7886041
conversion_datetime: 2025-12-17 22:22:53.84437
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength    | Pharmaceutical Form   | Route of Administration   | Packaging        | Content   | Package size             |
|-----------------|-----------------|-------------|-----------------------|---------------------------|------------------|-----------|--------------------------|
| EU/1/05/308/001 | Aclasta         | 5 mg/100 ml | Solution for infusion | Intravenous use           | bottle (plastic) | 100 ml    | 1 bottle                 |
| EU/1/05/308/002 | Aclasta         | 5 mg/100 ml | Solution for infusion | Intravenous use           | bottle (plastic) | 100 ml    | 5 x 1 bottle (unit pack) |